Impact of the COVID-19 pandemic on adults with moderate-to-severe atopic dermatitis in the Dutch general population

por Zhang, Junfen, Loman, Laura, Kamphuis, Esmé, Schuttelaar, Marie L.A.
Publicado 2021

Efficacy and safety of oral alitretinoin versus oral azathioprine in patients with severe chronic hand eczema: Results from a prematurely discontinued randomized controlled trial

por Voorberg, Angelique N., Kamphuis, Esmé, Christoffers, Wietske A., Romeijn, Geertruida L. E., Oosterhaven, Jart A. F., Schuttelaar, Marie L. A.
Publicado 2022

Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28‐week clinical and biomarker results from the BioDay registry

por Kamphuis, Esmé, Boesjes, Celeste M., Loman, Laura, Bakker, Daphne S., Poelhekken, Mila, Zuithoff, Nicolaas P. A., Kamsteeg, Marijke, Romeijn, Geertruida L. E., van Wijk, Femke, de Bruin‐Weller, Marjolein S., de Graaf, Marlies, Schuttelaar, Marie L. A.
Publicado 2022

Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry

por BOESJES, Celeste M., KAMPHUIS, Esmé, ZUITHOFF, Nicolaas P. A., BAKKER, Daphne S., LOMAN, Laura, SPEKHORST, Lotte S., HAECK, Inge, KAMSTEEG, Marijke, VAN LYNDEN-VAN NES, Anneke M. T., GARRITSEN, Floor M., POLITIEK, Klaziena, OLDHOFF, Marja, DE GRAAF, Marlies, SCHUTTELAAR, Marie L. A., DE BRUIN-WELLER, Marjolein S.
Publicado 2022